Antimetabolite Immunosuppressant [EPC]

7441 reported adverse events

Drugs of this class: MYCOPHENILIC ACID MYCOPHENOLIC ACID

These side effects are most commonly reported by patients taking drugs of the Antimetabolite Immunosuppressant [EPC] class:

# Side effect Count
0 OFF LABEL USE 728
1 DRUG INEFFECTIVE 403
2 PRODUCT USE IN UNAPPROVED INDICATION 392
3 ACUTE KIDNEY INJURY 353
4 CYTOMEGALOVIRUS INFECTION 353
5 DIARRHOEA 316
6 COVID-19 279
7 DRUG INTERACTION 277
8 PYREXIA 267
9 NEUTROPENIA 261
See all common reactions for Antimetabolite Immunosuppressant [EPC]

Drugs of the Antimetabolite Immunosuppressant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CUTANEOUS MALACOPLAKIA 6 0.3158
1 HISTOPLASMOSIS CUTANEOUS 7 0.2917
2 DIABETIC MACROANGIOPATHY 8 0.2857
3 ANORECTAL VARICES 6 0.2400
4 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 5 0.2174
5 RHODOCOCCUS INFECTION 16 0.1584
6 MENINGOENCEPHALITIS AMOEBIC 6 0.1579
7 MALACOPLAKIA 14 0.1573
8 APOPTOSIS 34 0.1525
9 DONOR SPECIFIC ANTIBODY PRESENT 9 0.1500
See all enriched reactions for Antimetabolite Immunosuppressant [EPC]